SMTL ID : 6urc.3 (2 other biounits)

Crystal structure of IRE1a in complex with compound 18

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x QFV: 2-chloro-N-(6-methyl-5-{[3-(2-{[(3S)-piperidin-3-yl]amino}pyrimidin-4-yl)pyridin-2-yl]oxy}naphthalen-1-yl)benzene-1-sulfonamide(Non-covalent)

QFV.1: 22 residues within 4Å: Chain A: L.31, G.32, V.40, A.51, K.53, E.66, V.67, I.80, Y.82, I.94, I.96, E.97, L.98, C.99, A.100, A.101, E.105, H.146, L.149, S.164, D.165, F.166 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:L.31, A:A.51, A:K.53, A:V.67, A:I.80, A:Y.82, A:I.94, A:I.94, A:I.96, A:L.149, A:D.165 Hydrogen bonds: A:K.53, A:C.99, A:C.99, A:E.105, A:D.165, A:F.166 Water bridges: A:K.53

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harnoss, J.M. et al., Disruption of IRE1 alpha through its kinase domain attenuates multiple myeloma. Proc. Natl. Acad. Sci. U.S.A. (2019)

Release Date

2019-11-06

Peptides

Serine/threonine-protein kinase/endoribonuclease IRE1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase/endoribonuclease IRE1

Related Entries With Identical Sequence